Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches
Top Cited Papers
- 28 October 2002
- journal article
- review article
- Published by Springer Nature in Nature Neuroscience
- Vol. 5 (S11) , 1046-1050
- https://doi.org/10.1038/nn938
Abstract
Despite high enthusiasm, early attempts to develop clinical treatments based on animal research with neurotrophins were not successful. Here we survey clinical trials with neurotrophins, compared with neurotrophic factors of other gene families, and delineate the most likely reasons for their failure. We then suggest improved methods for regulated local supply of NTs to specific populations of neurons and discuss future therapeutic procedures evolving from the more detailed knowledge of the signal transduction pathways activated by neurotrophins via their receptors.Keywords
This publication has 50 references indexed in Scilit:
- Neurotrophic cross‐talk between the nervous and immune systems: Implications for neurological diseasesAnnals of Neurology, 2003
- The many faces of p75NTRCurrent Opinion in Neurobiology, 2002
- Nerve Growth Factor Signaling, Neuroprotection, and Neural RepairAnnual Review of Neuroscience, 2001
- Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous systemGenes & Development, 2000
- Neurotrophin signal transduction in the nervous systemCurrent Opinion in Neurobiology, 2000
- The response of motoneurons to neurotrophinsNeurochemical Research, 1996
- Neurotrophic factors: from molecule to manTrends in Neurosciences, 1994
- The nerve growth factor familyProgress in Growth Factor Research, 1990
- Amelioration of cholinergic neuron atrophy and spatial memory impairment in aged rats by nerve growth factorNature, 1987
- Nerve growth factor and Alzheimer's diseaseAnnals of Neurology, 1986